Pictet Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.5M Sell
756,328
-12,448
-2% -$867K 0.05% 318
2025
Q4
$51M Buy
768,776
+1,611
+0.2% +$104K 0.05% 324
2025
Q3
$51.6M Sell
767,165
-38,715
-5% -$3.06M 0.05% 321
2025
Q2
$70.3M Sell
805,880
-74,779
-8% -$5.86M 0.07% 253
2025
Q1
$60.1M Buy
880,659
+218,040
+33% +$17.8M 0.07% 278
2024
Q4
$51.5M Sell
662,619
-10,420
-2% -$771K 0.06% 291
2024
Q3
$45.1M Sell
673,039
-24,602
-4% -$2.02M 0.05% 310
2024
Q2
$79.1M Sell
697,641
-56,059
-7% -$7.09M 0.09% 219
2024
Q1
$105M Sell
753,700
-13,849
-2% -$1.74M 0.11% 202
2023
Q4
$95.2M Buy
767,549
+111,058
+17% +$11.3M 0.11% 209
2023
Q3
$61.3M Buy
+656,491
New +$74M 0.08% 260

Other funds holding DXCM

Pictet Asset Management's DXCM Position: Q1 2026 in Review

Pictet Asset Management reduced its DexCom (DXCM) stake by 1.6% in Q1 2026, selling an estimated $867K and leaving 756,328 shares worth $47.5M. The position accounts for 0.05% of the portfolio, ranked #318.

Pictet Asset Management first reported a position in DXCM in Q3 2023 and has held it in 11 quarters since. The position peaked at $105M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Pictet Asset Management held 756,328 shares of DexCom worth $47.5M as of Q1 2026.
  • Pictet Asset Management sold 12,448 DexCom shares in Q1 2026, an estimated $867K.
  • DexCom made up 0.05% of Pictet Asset Management's portfolio in Q1 2026, its #318 holding.
  • Pictet Asset Management first reported a position in DexCom in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's DexCom position peaked at $105M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.